FDA Inspection 1172700 — U Of Southern California Hlth Sci Ctr LA (LAC + USC) IRB
The FDA completed an inspection of U Of Southern California Hlth Sci Ctr LA (LAC + USC) IRB on Jun 17, 2022 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 17, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Los Angeles, CA (United States)
Additional Details
IRB